Literature DB >> 23187863

An overview of transporter information in package inserts of recently approved new molecular entities.

Sheetal Agarwal1, Leslie Chinn, Lei Zhang.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23187863     DOI： 10.1007/s11095-012-0924-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  8 in total

1.  The International Transporter Consortium: a collaborative group of scientists from academia, industry, and the FDA.

Authors:  S-M Huang; L Zhang; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2010-01       Impact factor: 6.875

Review 2.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

Review 3.  The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins.

Authors:  Wen Jin Hua; Wei Xiao Hua; Hu Jin Fang
Journal:  Cardiovasc Ther       Date:  2011-05-25       Impact factor: 3.023

4.  Review of P-gp inhibition data in recently approved new drug applications: utility of the proposed [I(1) ]/IC(50) and [I(2) ]/IC(50) criteria in the P-gp decision tree.

Authors:  Sheetal Agarwal; Vikram Arya; Lei Zhang
Journal:  J Clin Pharmacol       Date:  2013-02       Impact factor: 3.126

5.  Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.

Authors:  Yoshihisa Shitara; Kumiko Takeuchi; Yoshiko Nagamatsu; Satomi Wada; Yuichi Sugiyama; Toshiharu Horie
Journal:  Drug Metab Pharmacokinet       Date:  2012-01-13       Impact factor: 3.614

6.  Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan.

Authors:  Anshul Gupta; Yang Dai; R Robert Vethanayagam; Mary F Hebert; Kenneth E Thummel; Jashvant D Unadkat; Douglas D Ross; Qingcheng Mao
Journal:  Cancer Chemother Pharmacol       Date:  2006-01-11       Impact factor: 3.333

Review 7.  A regulatory viewpoint on transporter-based drug interactions.

Authors:  L Zhang; Y D Zhang; J M Strong; K S Reynolds; S-M Huang
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

8.  Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: the role of P-glycoprotein in the disposition of aliskiren.

Authors:  Sujata Vaidyanathan; Gian Camenisch; Helmut Schuetz; Christine Reynolds; Ching-Ming Yeh; Marie-Noelle Bizot; Hans Armin Dieterich; Dan Howard; William P Dole
Journal:  J Clin Pharmacol       Date:  2008-09-10       Impact factor: 3.126
  8 in total
  2 in total

1.  Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.

Authors:  Qingcheng Mao; Yurong Lai; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2018-05       Impact factor: 3.922

2.  Proteoliposomes as tool for assaying membrane transporter functions and interactions with xenobiotics.

Authors:  Mariafrancesca Scalise; Lorena Pochini; Nicola Giangregorio; Annamaria Tonazzi; Cesare Indiveri
Journal:  Pharmaceutics       Date:  2013-09-18       Impact factor: 6.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.